JB Chemicals & Pharmaceuticals to acquire brands from Sanzyme

27 Jan 2022 Evaluate

JB Chemicals & Pharmaceuticals is planning to acquire brands for the India market from Sanzyme (Sanzyme), a leading player in the probiotics and reproductive health segment in the country. The transaction is valued at Rs 628 crore and is expected to be completed in the next two weeks subject to customary closing formalities.

Sanzyme, ranked amongst the top five probiotics players in the country, is engaged in the manufacture, distribution and marketing of specialty probiotics formulations, infertility management products and nutraceuticals products. Following the acquisition, these products will derive significant visibility by leveraging company’s distribution network across the country. The acquisition will mark company’s entry into the fast-growing probiotics, therapeutic nutraceuticals and reproductive health market with attractive set of brands.

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

1865.70 7.60 (0.41%)
24-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.60
Dr. Reddys Lab 1351.25
Cipla 1475.90
Lupin 2168.30
Zydus Lifesciences 964.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.